Old Port Advisors Lowers Stock Holdings in Haleon plc (NYSE:HLN)

Old Port Advisors trimmed its stake in shares of Haleon plc (NYSE:HLN) by 10.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,570 shares of the company’s stock after selling 2,958 shares during the quarter. Old Port Advisors’ holdings in Haleon were worth $217,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of HLN. Janney Montgomery Scott LLC lifted its holdings in Haleon by 182.3% in the first quarter. Janney Montgomery Scott LLC now owns 438,833 shares of the company’s stock valued at $3,726,000 after acquiring an additional 283,410 shares during the period. Capstone Investment Advisors LLC acquired a new position in Haleon during the first quarter worth $1,969,000. Wellington Management Group LLP boosted its position in Haleon by 164.6% during the fourth quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after purchasing an additional 8,423,475 shares in the last quarter. Patrick M Sweeney & Associates Inc. acquired a new stake in Haleon in the fourth quarter valued at $1,083,000. Finally, Douglas Lane & Associates LLC increased its position in shares of Haleon by 2.1% in the first quarter. Douglas Lane & Associates LLC now owns 8,401,876 shares of the company’s stock valued at $71,332,000 after buying an additional 175,082 shares in the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Trading Up 3.2 %

NYSE:HLN traded up $0.30 during trading hours on Friday, reaching $9.63. 6,995,874 shares of the company were exchanged, compared to its average volume of 4,408,089. Haleon plc has a 52-week low of $7.70 and a 52-week high of $9.73. The stock has a 50 day simple moving average of $8.65 and a 200 day simple moving average of $8.43. The firm has a market cap of $43.97 billion, a price-to-earnings ratio of 32.10, a PEG ratio of 2.69 and a beta of 0.24. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73.

Haleon (NYSE:HLN) last issued its earnings results on Thursday, August 1st. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). The firm had revenue of $3.50 billion during the quarter, compared to analyst estimates of $3.55 billion. Haleon had a net margin of 9.71% and a return on equity of 19.85%. During the same quarter in the previous year, the business posted $0.08 EPS. As a group, analysts predict that Haleon plc will post 0.47 EPS for the current year.

Haleon Cuts Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 19th. Shareholders of record on Friday, August 16th will be paid a dividend of $0.0514 per share. The ex-dividend date of this dividend is Friday, August 16th. This represents a yield of 1.6%. Haleon’s dividend payout ratio is currently 70.00%.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Berenberg Bank assumed coverage on shares of Haleon in a report on Wednesday, June 5th. They issued a “buy” rating on the stock. HSBC initiated coverage on shares of Haleon in a research report on Wednesday, April 17th. They issued a “buy” rating for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.